Fondaparinux Sodium
25 NDCs across 5 manufacturers|25 Generic,0 Brand
Fondaparinux Sodium is used to treat pulmonary embolism and venous thrombosis, per the National Library of Medicine's MED-RT classification.
▸ More about this market▾ Less
The brand product was first FDA-approved on Dec 7, 2001, and the first generic was approved Jul 11, 2011. In 2024, Medicare Part D spent $15 million on Fondaparinux Sodium across 13,000 claims for 2,726 beneficiaries.
Fondaparinux Sodium is available as 25 NDCs from 5 manufacturers (25 generic, 0 brand), with NADAC prices from $12.12 to $55.31 per ML — the most expensive product costs about 4.6× the cheapest. Every pack size and labeler in this drug market is compared side-by-side below.
Total NDCs
25
25G / 0B
Manufacturers
5
competing in market
Price Spread
$12.12 – $55.31
per ML
7d Activity
avg -1.2% WoW · of 25 NDCs
Market Price Trend
Monthly average NADAC per unit, split by generic and brand.
Explore this market from other angles
Move from the molecule page into the supplier, class, and trend views that create the strongest internal-link cluster for this market.
Top supplier
Dr. Reddy's Laboratories Inc. manufacturer profile
Open the supplier page for the manufacturer with the strongest footprint in this market.
Lead class
Factor Xa Inhibitor class view
See how this market rolls up into the broader therapeutic class and compare other drugs in the same bucket.
Trend hub
Latest market trends
Move from this single molecule into the current cross-market mover and volatility view.
Guide
How to interpret NADAC
Review the benchmark methodology behind the prices and spreads shown on this market page.
Manufacturer Breakdown
5 manufacturers producing FONDAPARINUX SODIUM
Frequently Asked Questions
What is Fondaparinux Sodium used to treat?
Fondaparinux Sodium is used to treat pulmonary embolism and venous thrombosis, per the National Library of Medicine's MED-RT classification.
When did Fondaparinux Sodium become available as a generic?
FDA approved the first generic Fondaparinux Sodium (ANDA) on Jul 11, 2011.
How much does Medicare spend on Fondaparinux Sodium?
In 2024, Medicare Part D spent $15 million on Fondaparinux Sodium across 13,000 claims for 2,726 beneficiaries.
How many Fondaparinux Sodium products are on the market?
The Fondaparinux Sodium drug market contains 25 NDCs from 5 manufacturers — 25 generic and 0 brand products.
What is the price range for Fondaparinux Sodium?
NADAC reference prices for Fondaparinux Sodium range from $12.1247 to $55.3125 per ML — the most expensive product costs about 4.6× the cheapest.
Which manufacturers make Fondaparinux Sodium?
5 manufacturers list Fondaparinux Sodium in NADAC. Ranked by number of NDCs, the largest are Dr. Reddy's Laboratories Inc. (7), Zydus Pharmaceuticals (USA) Inc. (6), Mylan Institutional LLC (4), Eugia US LLC (4), Sandoz Inc. (4).
How has the price of Fondaparinux Sodium changed recently?
Over the past 7 days, 5 Fondaparinux Sodium NDCs rose and 6 fell, with a market-wide average change of -1.2%.